# Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

> PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31408164-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31408164-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31408164-teriparatide-v1.json
- Content SHA-256: `6b489eb65a232374cc7cf6d2fe565ba2b911896554e5982e899b59faf9a9c35f`

## Claims and source pins

### Headline

Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use". ([`pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c`](#source-pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c))

### Summary

PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c`](#source-pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c))

### Paragraph 1

PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c`](#source-pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c`](#source-pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c))

## Sources

<a id="source-pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c"></a>
- **Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use". · retained source version 1:2026-08-13:current:0c195f7d324c89cff9eb353f7b605ec0a8fce5cef121d97d66b320fe11d22cd8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31408164/) (`pubmed-observation-pmid-31408164-2026-08-13-0c195f7d324c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Letter to the Editor: 'Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use'." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31408164-teriparatide-v1.json SHA-256: 6b489eb65a232374cc7cf6d2fe565ba2b911896554e5982e899b59faf9a9c35f.